Showing results (251-260 of 781) with videos related to

Sort By:
Pageof 79
Blood|September 14, 2014
Pyk2 promotes tumor progression in multiple myelomaYu Zhang, Michele Moschetta, Daisy Huynh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jawNoopur Raje, Sook-Bin Woo, Karen Hande, et al.
Blood Cancer Discovery|July 16, 2021
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow MicroenvironmentGiada Bianchi, Peter G Czarnecki, Matthew Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myelomaTeru Hideshima, Jun Qi, Ronald M Paranal, et al.
Clinical Lymphoma & Myeloma|June 27, 2006
CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disordersDaniel Ditzel Santos, Evdoxia Hatjiharissi, Olivier Tournilhac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myelomaGang An, Zengjun Li, Yu-Tzu Tai, et al.
Nature Reviews. Cancer|July 25, 2007
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targetsTeru Hideshima, Constantine Mitsiades, Giovanni Tonon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2003
Proteasome inhibitors disrupt the unfolded protein response in myeloma cellsAnn-Hwee Lee, Neal N Iwakoshi, Kenneth C Anderson, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Tanespimycin as antitumor therapyMeletios-Athanassios Dimopoulos, Constantine S Mitsiades, Kenneth C Anderson, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
From the bench to the bedside: emerging new treatments in multiple myelomaConstantine S Mitsiades, Patrick J Hayden, Kenneth C Anderson, et al.
Pageof 79